Cytotoxicity and antigenotoxicity evaluation of acetylshikonin and shikonin

References

• Andrade, A.F., et al., 2016. In vitro cytotoxicity, genotoxicity and antigenotoxicity assessment of Solanum lycocarpum hydroalcoholic extract. Pharmaceutical Biology, 54 (11), 2786–2790.
   PubMed Web of Science ®Google Scholar
• Bacanlı, M., Başaran, A.A., and Başaran, N., 2017. The antioxidant, cytotoxic, and antigenotoxic effects of galangin, puerarin, and ursolic acid in mammalian cells. Drug and Chemical Toxicology, 40 (3), 256–262.
   PubMed Web of Science ®Google Scholar
• Bez, G., et al., 2001. Investigation of genotoxic and antigenotoxic activities of chlorophylls and chlorophyllin in cultured V79 cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 497 (1–2), 139–145.
   PubMed Web of Science ®Google Scholar
• Bhatia, A., et al., 2011. Anticancer potential of himalayan plants. Phytochemistry Reviews, 10 (3), 309–323.
   Web of Science ®Google Scholar
• Daqian, W., et al., 2015. Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling. Chemico-Biological Interactions, 237, 25–30.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 2007. Cytokinesis-block micronucleus cytome assay. Nature Protocols, 2 (5), 1084–1104.
   PubMed Web of Science ®Google Scholar
• Fotakis, G., and Timbrell, J.A., 2006. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicology Letters, 160 (2), 171–177.
   PubMed Web of Science ®Google Scholar
• Gara, R.K., et al., 2015. Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway. Journal of Biomedical Science, 22, 1–12.
   PubMed Web of Science ®Google Scholar
• Hasenoehrl, C., et al., 2017. Anti-tumor effects of shikonin derivatives on human medullary thyroid carcinoma cells. Endocrine Connections, 6 (2), 53–62.
   PubMed Web of Science ®Google Scholar
• Jeung, Y.J., et al., 2016. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863, 2584–2593.
   PubMed Web of Science ®Google Scholar
• Jing, H., et al., 2016. Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways. Molecular Medicine Reports, 13 (4), 3009–3016.
   PubMed Web of Science ®Google Scholar
• Kim, D.J., et al., 2016. Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis. Archives of Oral Biology, 70, 149–157.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Gautam, S., and Sharma, A., 2013. Antimutagenic and antioxidant properties of plumbagin and other naphthoquinones. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 755 (1), 30–41.
   PubMed Web of Science ®Google Scholar
• Leandro, L.F., et al., 2013. Assessment of the genotoxicity and antigenotoxicity of (+)-usnic acid in V79 cells and swiss mice by the micronucleus and comet assays. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 753 (2), 101–106.
   PubMed Web of Science ®Google Scholar
• Malik, S., et al., 2011. Physico-chemical factors influencing the shikonin derivatives production in cell suspension cultures of Arnebia euchroma (Royle) Johnston, a medicinally important plant species. Cell Biology International, 35 (2), 153–158.
   PubMed Web of Science ®Google Scholar
• Maron, D.M., and Ames, B.N., 1983. Revised methods for the Salmonella mutagenicity test. Mutation Research/Environmental Mutagenesis and Related Subjects, 113 (3–4), 173–215.
   PubMed Web of Science ®Google Scholar
• Nishizawa, M., et al., 2005. Presence of peroxyradicals in cigarette smoke and the scavenging effect of shikonin, a naphthoquinone pigment. Chemical and Chemical and Pharmaceutical Bulletin, 53 (7), 796–799.
   PubMed Web of Science ®Google Scholar
• Oliveira, R.J., et al., 2006. Evaluation of antimutagenic activity and mechanisms of action of β-glucan from barley, in CHO-k1 and HTC cell lines using the micronucleus test. Toxicology in Vitro, 20 (7), 1225–1233.
   PubMed Web of Science ®Google Scholar
• Papageorgiou, V.P., et al., 1999. The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angewandte Chemie International Edition, 38 (3), 270–301.
   PubMed Web of Science ®Google Scholar
• Pietrosiuk, A., and Wiedenfeld, H., 2005. Shikonin derivatives from Lithospermum canescens. Pharmaceutical Biology, 43 (2), 189–191.
   Web of Science ®Google Scholar
• Senthilkumar, S., et al., 2006. Effect of squalene on cyclophosphamide-induced toxicity. Clinica Chimica Acta, 364 (1–2), 335–342.
   PubMed Web of Science ®Google Scholar
• Skrzypczak, A., et al., 2015. Antigenotoxic, antiphotogenotoxic and antioxidant activities of natural naphthoquinone shikonin and acetylshikonin and Arnebia euchroma callus extracts evaluated by the umutest and EPR method. Toxicology in Vitro, 30 (1), 364–372.
   PubMed Web of Science ®Google Scholar
• Słoczynska, K., et al., 2014. Antimu-´ tagenic compounds and their possible mechanisms of action. Journal of Applied Genetics, 55, 273–285.
   PubMed Web of Science ®Google Scholar
• Trindade, C., et al., 2015. Antigenotoxic and antimutagenic effects of diphenyl ditelluride against several known mutagens in Chinese hamster lung fibroblasts. Mutagenesis, 30 (6), 799–809.
   PubMed Web of Science ®Google Scholar
• Trindade, C., et al., 2016. Antimutagenic and antioxidant properties of the aqueous extracts of organic and conventional grapevine Vitis labrusca cv. Isabella leaves in V79 cells. Journal of Toxicology and Environmental Health, Part A, 79 (18), 825–836.
   PubMed Web of Science ®Google Scholar
• Wang, R.B., et al., 2014. Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach. ChemMedChem, 9 (12), 2798–2808.
   PubMed Web of Science ®Google Scholar
• Waters, M.D., et al., 1990. Antimutagenicity profiles for some model compounds. Mutation Research/Reviews in Genetic Toxicology, 238 (1), 57–85.
   Google Scholar
• Wei, P.L., et al., 2013. Shikonin suppresses the migratory ability of hepatocellular carcinoma cells. Journal of Agricultural and Food Chemistry, 61 (34), 8191–8197.
   PubMed Web of Science ®Google Scholar
• Wiench, B., et al., 2012. Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells. Evidence Based Complementary and Alternative Medicine eCAM, 2012, 1.
   Web of Science ®Google Scholar
• Williams, G.M., et al., 2013. Relationship of cellular topoisomerase IIα inhibition to cytotoxicity and published genotoxicity of fluoroquinolone antibiotics in V79 cells. Chemico-Biological Interactions, 203 (2), 386–390.
   PubMed Web of Science ®Google Scholar
• Wu, H., et al., 2013. Anticancer agent shikonin is an incompetent inducer of cancer drug resistance. PLoS ONE, 8, 1–7.
   Web of Science ®Google Scholar
• Xiong, W., et al., 2009. In vitro and in vivo antitumor effects of acetylshikonin isolated from Arnebia euchroma (Royle) Johnst (Ruanzicao) cell suspension cultures. Chinese Medicine, 4, 1–7.
   PubMedGoogle Scholar
• Xuan, Y., and Hu, X., 2009. Naturally-occurring shikonin analogues – a class of necroptotic inducers that circumvent cancer drug resistance. Cancer Letters, 274 (2), 233–242.
   PubMed Web of Science ®Google Scholar
• Yan, Y., et al., 2015. Shikonin promotes skin cell proliferation and inhibits nuclear factor-κb translocation via proteasome inhibition in vitro. Chinese Medical Journal, 128 (16), 2228–2233.
   PubMed Web of Science ®Google Scholar
• Yang, Y.Y., et al., 2016. Shikonin derivative DMAKO-05 inhibits Akt signal activation and melanoma proliferation. Chemical Biology and Drug Design, 87 (6), 895–904.
   PubMed Web of Science ®Google Scholar
• Yingkun, N., Lvsong, Z., and Huimin, Y., 2010. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells. Canadian Journal of Physiology and Pharmacology, 88 (12), 1138–1146.
   PubMed Web of Science ®Google Scholar
• Yoshida, L.S., et al., 2014. Evaluation of radical scavenging properties of shikonin. Journal of Clinical Biochemistry and Nutrition, 55 (2), 90–96.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2005. Metabolism and transport of oxazaphosphorines and the clinical implications. Drug Metabolism Reviews, 37, 611–703.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2018. Advance in anti-tumor mechanisms of shikonin, alkannin and their derivatives. Mini-Reviews in Medicinal Chemistry, 18, 164–172.
   PubMed Web of Science ®Google Scholar